Clinical relevance of cytogenetics in myelodysplastic syndromes.

@article{Bernasconi2006ClinicalRO,
  title={Clinical relevance of cytogenetics in myelodysplastic syndromes.},
  author={P. Bernasconi and Marina Boni and Paola Maria Cavigliano and Silvia Calatroni and Ilaria Giardini and Barbara Rocca and Rita Zappatore and Irene Dambruoso and Marilena Caresana},
  journal={Annals of the New York Academy of Sciences},
  year={2006},
  volume={1089},
  pages={
          395-410
        }
}
Myelodysplastic syndromes (MDS) are a group of heterogeneous stem cell disorders with different clinical behaviors and outcomes. Conventional cytogenetics (CC) studies have demonstrated that the majority of MDS patients harbor clonal chromosome defects. The probability of discovering a chromosomal abnormality has been increased by fluorescence in situ hybridization (FISH), which has revealed that about 15% of patients with a normal chromosome pattern on CC may instead present cryptic defects… CONTINUE READING
Highly Cited
This paper has 45 citations. REVIEW CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Myelodysplastic syndrome in elderly patients: correlation of CBC with cytogenetic and FISH analysis.

International journal of laboratory hematology • 2010
View 9 Excerpts
Highly Influenced

Cytogenetic biomarkers for human cancer.

Frontiers in bioscience : a journal and virtual library • 2008
View 4 Excerpts
Highly Influenced